EV/EBITDA
3.41
+0.02+0.59%
Wed, 27 Nov 2024 21:00:09 GMT
Summary:
PharmaCyte Biotech EV/EBITDA is currently 3.41, with a rise of +0.02 (+0.59%) during the most recent trading day. Over the past year, it has dropped by -5.58 (-62.07%). PMCB EV/EBITDA is now -72.65% below its all-time high of 12.47.PMCB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +0.6% |
| 1 m1 month | +3.6% |
| 3 m3 months | -6.8% |
| 6 m6 months | -32.6% |
| ytdytd | -63.1% |
| 1 y1 year | -62.1% |
| 5 y5 years | +129.1% |
PMCB EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 3.56 | -4.2% | 3.04 | +12.2% |
| 3 m | 3 months | 3.80 | -10.3% | 2.96 | +15.2% |
| 6 m | 6 months | 5.39 | -36.7% | 2.96 | +15.2% |
| 1 y | 1 year | 9.34 | -63.5% | 2.96 | +15.2% |
| 3 y | 3 years | 12.47 | -72.7% | 2.94 | +16.0% |
| 5 y | 5 years | 12.47 | -72.7% | -23.45 | +114.5% |
| alltime | all time | 12.47 | -72.7% | -61.09 | +105.6% |
PharmaCyte Biotech EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 3.41(-63.1%) |
| 2023 | 9.23(+142.3%) |
| 2022 | 3.81(-59.7%) |
| 2021 | 9.45(-361.0%) |
| 2020 | -3.62(-75.0%) |
| 2019 | -14.50(+97.0%) |
| Date | Value |
|---|---|
| 2018 | -7.36(-18.3%) |
| 2017 | -9.01(-65.7%) |
| 2016 | -26.23(+574.3%) |
| 2015 | -3.89(-50.3%) |
| 2014 | -7.82(+40.1%) |
| 2013 | -5.58 |
FAQ
- What is PharmaCyte Biotech EV/EBITDA?
- What is the all time high EV/EBITDA for PharmaCyte Biotech?
- What is PMCB EV/EBITDA year-to-date change?
- What is PharmaCyte Biotech EV/EBITDA year-on-year change?
What is PharmaCyte Biotech EV/EBITDA?
The current EV/EBITDA of PMCB is 3.41
What is the all time high EV/EBITDA for PharmaCyte Biotech?
PharmaCyte Biotech all-time high EV/EBITDA is 12.47
What is PMCB EV/EBITDA year-to-date change?
PharmaCyte Biotech EV/EBITDA has changed by -5.82 (-63.06%) since the beginning of the year
What is PharmaCyte Biotech EV/EBITDA year-on-year change?
Over the past year, PMCB EV/EBITDA has changed by -5.58 (-62.07%)